According to a series of eight interim reports obtained by the author in November 2024, the Department of Defense (DOD) engaged in a longitudinal SARS-CoV-2 (coronavirus) seroprevalence study of 29,000 members of the U.S. military between May 2020 and June 2021. Active, Guard, and Reserve components were included in the study.
Each document is marked “For Official Use Only” or “Controlled Unclassified Information” in a preventative measure to avoid being released outside of DOD.
Despite the risk, the revealing documents were provided to Children’s Health Defense by an unnamed military whistleblower.
Seroprevalence can be defined as the percentage of a population who have the presence of neutralizing antibodies in their blood, showing they have been exposed to a virus or other infectious agent.
A seroprevalence study can be a helpful indicator of the development of herd immunity, which occurs when a large portion of a population becomes immune to a disease through infection or vaccination, making it difficult to spread.
According to one peer-reviewed article published by The Cureus Journal of Medical Science, “Several analysts predict the criterion at 60-70% of the community acquiring immunity from immunization or recent infection with the [coronavirus] pathogen.”
Dr. Anthony Fauci, the former